Jonathan F Head

Summary

Publications

  1. ncbi Infrared imaging: making progress in fulfilling its medical promise
    Jonathan F Head
    IEEE Eng Med Biol Mag 21:80-5. 2002
  2. ncbi Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells
    Ding Cheng Yang
    Mastology Research Institute of The E.H.H. Breast Cancer Research and Treatment Center, Baton Rouge, LA 70816, USA
    Anticancer Res 22:1513-24. 2002
  3. ncbi Gene targets of antisense therapies in breast cancer
    Ding Cheng Yang
    Mastology Research Institute, Head Breast Cancer Research and Treatment Center, Baton Rouge, LA 70816, USA
    Expert Opin Ther Targets 6:375-85. 2002
  4. ncbi Radiofrequency ablation of a stereotactically localized nonpalpable breast carcinoma
    Robert L Elliott
    The Elliott Head Breast Cancer Research and Treatment Center, Baton Rouge, Louisiana 70816, USA
    Am Surg 68:1-5. 2002
  5. ncbi Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo
    Xian P Jiang
    Mastology Research Institute, Elliott-Hailey-Head Breast Cancer Research and Treatment Center, 17050 Medical Center Drive, 4th Floor, Baton Rouge, LA 70816, USA
    Anticancer Res 22:2685-92. 2002
  6. ncbi Re: Minimally invasive breast surgery (evolution, expansion, and what's on the horizon)
    Robert L Elliott
    Am Surg 69:631-3. 2003
  7. ncbi Complete resolution of malignant ascites in stage IV breast cancer by peritoneal drainage and innovative chemoimmunotherapy: a case report
    Robert L Elliott
    Elliott, Elliott, Head Breast Cancer Research and Treatment Center, Baton Rouge, LA 70816, USA
    Cancer Biother Radiopharm 21:138-45. 2006

Collaborators

  • Robert L Elliott
  • Ding Cheng Yang
  • Xian P Jiang
  • Pamela B Rice
  • Fen Wang
  • Ding C Yang
  • Alan J Ostrowe
  • Joe A Suits
  • Xianpeng Jiang

Detail Information

Publications7

  1. ncbi Infrared imaging: making progress in fulfilling its medical promise
    Jonathan F Head
    IEEE Eng Med Biol Mag 21:80-5. 2002
  2. ncbi Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells
    Ding Cheng Yang
    Mastology Research Institute of The E.H.H. Breast Cancer Research and Treatment Center, Baton Rouge, LA 70816, USA
    Anticancer Res 22:1513-24. 2002
    ....
  3. ncbi Gene targets of antisense therapies in breast cancer
    Ding Cheng Yang
    Mastology Research Institute, Head Breast Cancer Research and Treatment Center, Baton Rouge, LA 70816, USA
    Expert Opin Ther Targets 6:375-85. 2002
    ..However, in order to determine their feasibility antisense therapies need to be further investigated to determine their antitumour activity, pharmacokinetics and toxicity in breast cancer patients...
  4. ncbi Radiofrequency ablation of a stereotactically localized nonpalpable breast carcinoma
    Robert L Elliott
    The Elliott Head Breast Cancer Research and Treatment Center, Baton Rouge, Louisiana 70816, USA
    Am Surg 68:1-5. 2002
    ..Additional ablations will be required to define the procedure but the results from this initial patient suggest that this is a promising minimally invasive curative approach for nonpalpable breast lesions...
  5. ncbi Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo
    Xian P Jiang
    Mastology Research Institute, Elliott-Hailey-Head Breast Cancer Research and Treatment Center, 17050 Medical Center Drive, 4th Floor, Baton Rouge, LA 70816, USA
    Anticancer Res 22:2685-92. 2002
    ..05 and p < 0.01, respectively, Student's t-test). This is the first report of iron depletion caused by a low iron diet or deferoxamine mesylate treatment inducing apoptosis in rats bearing the 13762NF marnmary adenocarcinoma...
  6. ncbi Re: Minimally invasive breast surgery (evolution, expansion, and what's on the horizon)
    Robert L Elliott
    Am Surg 69:631-3. 2003
  7. ncbi Complete resolution of malignant ascites in stage IV breast cancer by peritoneal drainage and innovative chemoimmunotherapy: a case report
    Robert L Elliott
    Elliott, Elliott, Head Breast Cancer Research and Treatment Center, Baton Rouge, LA 70816, USA
    Cancer Biother Radiopharm 21:138-45. 2006
    ..We are reporting a case of complete remission of malignant ascites in a stage IV breast cancer patient. Her condition was managed by a peritoneal dialysis catheter and an aggressive intraperitoneal innovative chemoimmunotherapy protocol...